Provider communication style and treatment intensification in uncontrolled hypertension
Abstract
Rationale, Aims and Objectives: Provider decisions to intensify antihypertensive medications are usually based on clinical metrics (i.e., blood pressure control), but may also be based on patient provided information. When providers use a participatory questioning style, patients share more information and providers may identify barriers to blood pressure control other than an inadequate medication regimen, such as poor adherence. Providers may in turn focus on such barriers rather than intensify treatment. We examined how providers’ question style influenced their treatment intensification for uncontrolled hypertension.
Methods: We used qualitative and quantitative methods to analyze data from 43 audiorecorded clinical encounters. Transcripts were coded according to a priori categories including provider question style (open- and/or closed-ended) and whether treatment was intensified, as determined by interpretation of providers’ verbalizations. We used Fisher’s exact test to evaluate the association of provider questioning style with treatment intensification.
Results: Providers used a mix of open- and closed-ended questions less frequently than they used closed-ended questions alone. Treatment intensification was less common when a mix of questions was used instead of closed-ended questions alone, although this difference did not reach statistical significance (29% vs. 73% of instances, p=0.07).
Conclusions: Provider communication that invites patient participation may elicit more information about patient behavior, but may not impact decisions about treatment intensification in uncontrolled hypertension. Future studies should examine this question among a larger sample and investigate the relationship of participatory communication to improvements in blood pressure control.
Keywords
Full Text:
PDFReferences
Heisler, M., Hogan, M.M., Hofer, T.P., Schmittdiel, J.A., Pladevall, M. & Kerr, E.A. (2008). When More Is Not Better: Treatment Intensification Among Hypertensive Patients With Poor Medication Adherence. Circulation 117 (22) 2884-2892.
Golin, C.E., DiMatteo, M.R. & Gelberg. L. (1996). The role of patient participation in the doctor visit. Implications for adherence to diabetes care. Diabetes Care 19 (10) 1153-1164.
Bokhour, B.G., Berlowitz, D.R., Long, J.A. & Kressin, N.R. (2006). How do providers assess antihypertensive medication adherence in medical encounters? Journal of General Internal Medicine 21 (6) 577-583.
Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo Jr., J.L., Jones, D.W., Materson, B.J., Oparil, S., Wright, Jr., J.T., Roccella, E.J. & National High Blood Pressure Education Programme Coordinating Committee. (2003). Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (6) 1206-1252.
Morse, J.M. (2004). Sampling in Qualitative Research. Thousand Oaks, CA: Sage Publications, Inc.
NUD*IST VIVO (NVIVO) (1999). Melbourne, Australia: Pty. Ltd.
Roter, D. & Frankel, R. (1992). Quantitative and qualitative approaches to the evaluation of the medical dialogue. Social Science & Medicine 34 (10) 1097-1103.
Arbuthnott, A. & Sharpe, D. (2009). The effect of physician-patient collaboration on patient adherence in non-psychiatric medicine. Patient Education and Counseling 77 (1) 60-67.
Manze, M., Rose, A.J., Orner, M.B., Berlowitz, D.R. & Kressin, N.R. (2010). Understanding racial disparities in treatment intensification for hypertension management. Journal of General Internal Medicine 25 (8) 819-825.
Kerr, E.A., Zikmund-Fisher, B.J., Klamerus, M.L., Subramanian, U., Hogan, M.M. & Hofer, T.P. (2008). The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Annals of Internal Medicine 148 (10) 717-727.
Steele, D.J., Jackson, T.C. & Gutmann, M.C. (1990). Have you been taking your pills? The adherence-monitoring sequence in the medical interview. Journal of Family Practice 30 (3) 294-299.
Miller, L.G., Liu, H., Hays, R.D., Golin, C.E., Beck, C.K., Asch, S.M., Ma, Y., Kaplan, A.H. & Wengter, N.S. (2002). How well do clinicians estimate patients' adherence to combination antiretroviral therapy? Journal of General Internal Medicine 17 (1) 1-11.
Meddings, J., Kerr, E.A., Heisler, M. & Hofer, T.P. (2012). Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss. BMC Health Services Research 12, 270.
Ogedegbe, G. (2008). Barriers to optimal hypertension control. Journal of Clinical Hypertension 10 (8) 644-646.
Rose, A.J., Berlowitz, D.R., Manze, M., Orner, M.B. & Kressin, N.R. (2009). Intensifying therapy for hypertension despite suboptimal adherence. Hypertension 54 (3) 524-529.
Giugliano, D. & Esposito, K. (2011). Clinical inertia as a clinical safeguard. Journal of the American Medical Association 305 (15) 1591-1592.
Ho, P.M., Magid, D.J., Shetterly, S.M., Olson, K.L., Peterson, P.N., Masoudi, F.A. & Rumsfeld, J.S. (2008). Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Archives of Internal Medicine 168 (3) 271-276.
Stephenson, J. (1999). Noncompliance may cause half of antihypertensive drug "failures". Journal of the American Medical Association 282 (4) 313-314.
DOI: http://dx.doi.org/10.5750/ejpch.v4i2.1164
Refbacks
- There are currently no refbacks.